Ab Initio Pharma
Major Drugs - N/A, N/A, au
Ab Initio Pharma Employees
Ab Initio Pharma Details
Ab Initio Pharma, a formulation and manufacturing company, established as a spinoff by the University of Sydney in partnership with Sydney Local Health Distinct and the peak industry body, ACRS will provide innovators with a flexible platform to rapidly translate bench-top discoveries to clinical trial products and fully-fledged commercial pharmaceuticals. Importantly, Ab Initio will have R&D facilities and be able to offer its partners formulation services to develop products suitable for clinical trials.
Ab Initio Pharma Technologies
Email Providers
Outlook
Domain Name Services
NSOne
Fonts
Typekit
Online Video Platforms
Vimeo
Other
Mobile Friendly
Similar companies to Ab Initio Pharma
Connect with Ab Initio Pharma Executives and Employees
Ab Initio Pharma is a leading biotechnology company that focuses on developing innovative therapies for improving human health. If you're looking for contact information for Ab Initio Pharma, ConnectPlex is the ideal platform to connect with professionals working in the company. Our extensive database provides accurate and up-to-date contact information for various companies, including Ab Initio Pharma. At ConnectPlex, we understand the importance of connecting with the right people in the industry. Our AI-based B2B lead generation products are designed to provide you with the most relevant and accurate contact information for Ab Initio Pharma. With our platform, you can easily find and connect with key decision-makers, executives, and professionals in Ab Initio Pharma, making it easier for you to establish meaningful business relationships and grow your network.
Ab Initio Pharma is a formulation and manufacturing company that was established as a spinoff by the University of Sydney in partnership with Sydney Local Health District and the peak industry body, ACRS. The company's mission is to provide innovators with a flexible platform to rapidly translate bench-top discoveries to clinical trial products and fully-fledged commercial pharmaceuticals. Ab Initio Pharma's state-of-the-art R&D facilities are equipped to offer its partners formulation services to develop products suitable for clinical trials. Located in Camperdown, New South Wales, Australia, Ab Initio Pharma is a small to medium-sized company with a revenue range of $1 to $2.5 million. The company operates in the major drugs industry and has a strong focus on research and development. With a team of 10 to 19 employees, Ab Initio Pharma is committed to providing innovative solutions to the pharmaceutical industry. The company's website, ab-initio-pharma.com, provides more information on their services and products. You can also find them on LinkedIn at http://www.linkedin.com/company/ab-initio-pharma.
Ab Initio Pharma is a company that helps turn ideas for new medicines into real products. It was started by the University of Sydney, Sydney Local Health District, and the Australian Clinical Research Services (ACRS). Ab Initio provides a flexible platform for researchers to quickly turn their ideas into products that can be tested in clinical trials and eventually sold to the public. The company has its own research and development facilities and can help its partners create products that are ready for clinical trials.